Kennedy Institute of Ethics Journal 21 (1):51-78 (2011)
Randomized and double-blind clinical trials are widely regarded as the most reliable way of studying the effects of medical interventions. According to received wisdom, if a new drug or treatment is to be accepted in clinical practice, its safety and efficacy must first be demonstrated in such trials. For ethical and scientific reasons, it is generally considered necessary to monitor a trial in various ways as it proceeds and to analyze data as they accumulate. Monitoring and interim analyses are often conducted by a so-called data monitoring committee (DMC), a group of experts independent of both sponsors and investigators. On the basis of DMC recommendations, sponsors sometimes decide to discontinue trials ..
|Keywords||No keywords specified (fix it)|
|Categories||categorize this paper)|
References found in this work BETA
No references found.
Citations of this work BETA
No citations found.
Similar books and articles
Principles of Early Stopping of Randomized Trials for Efficacy: A Critique of Equipoise and an Alternative Nonexploitation Ethical Framework.David Buchanan & Franklin G. Miller - 2005 - Kennedy Institute of Ethics Journal 15 (2):161-178.
Statistical Decisions and the Interim Analyses of Clinical Trials.Roger Stanev - 2011 - Theoretical Medicine and Bioethics 32 (1):61-74.
The Epistemology and Ethics of Early Stopping Decisions in Randomized Controlled Trials.Roger Stanev - 2012 - Dissertation, University of British Columbia
Using Empirical Data to Inform the Ethical Evaluation of Placebo Controlled Trials.Jeremy Sugarman - 2004 - Science and Engineering Ethics 10 (1):29-35.
Uncertainty and the Ethics of Clinical Trials.Sven Ove Hansson - 2006 - Theoretical Medicine and Bioethics 27 (2):149-167.
The Science and Ethics of Placebo in Pediatric Psychopharmacology.Lawrence Scahill, Mary Solanto & Joseph McGuire - 2008 - Ethics and Behavior 18 (2 & 3):266 – 285.
What Makes Placebo-Controlled Trials Unethical?Franklin G. Miller & Howard Brody - 2002 - American Journal of Bioethics 2 (2):3 – 9.
Compromised Ethical Principles in Randomised Clinical Trials of Distant, Intercessory Prayer.Peter Graeme Hobbins - 2005 - Journal of Bioethical Inquiry 2 (3):142-152.
Efficacy Testing as a Primary Purpose of Phase 1 Clinical Trials: Is It Applicable to First-in-Human Bionics and Optogenetics Trials?Frederic Gilbert, Alexander R. Harris & Robert M. I. Kapsa - 2012 - AJOB Neuroscience 3 (2):20-22.
Unique Ethical Concerns in Clinical Trials Comparing Psychosocial and Psychopharmalogical Interventions.Lisa R. Stines & Norah C. Feeny - 2008 - Ethics and Behavior 18 (2 & 3):234 – 246.
The Research Misconception.Maurie Markman - 2004 - International Journal of Applied Philosophy 18 (2):241-252.
Bayesian Versus Frequentist Clinical Trials.David Teira - 2011 - In Gifford Fred (ed.), Philosophy of Medicine [Handbook of Philosophy of Science, vol. 16],. Elsevier.
Resolving Ethical Issues in Stem Cell Clinical Trials: The Example of Parkinson Disease.Bernard Lo & Lindsay Parham - 2010 - Journal of Law, Medicine & Ethics 38 (2):257-266.
Added to index2011-04-28
Total downloads271 ( #11,378 of 2,153,474 )
Recent downloads (6 months)11 ( #60,163 of 2,153,474 )
How can I increase my downloads?